C
Coryse St Hillaire-Clarke
Researcher at National Institutes of Health
Publications - 8
Citations - 531
Coryse St Hillaire-Clarke is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Biomarker discovery & Representation (systemics). The author has an hindex of 5, co-authored 7 publications receiving 338 citations.
Papers
More filters
Journal ArticleDOI
Preclinical research in Rett syndrome: Setting the foundation for translational success
David M. Katz,Joanne Berger-Sweeney,James H. Eubanks,Monica J. Justice,Jeffrey L. Neul,Lucas Pozzo-Miller,Mary E. Blue,Diana Christian,Jacqueline N. Crawley,Maurizio Giustetto,Jacky Guy,C. James Howell,Miriam Kron,Sacha B. Nelson,Rodney C. Samaco,Laura Schaevitz,Coryse St Hillaire-Clarke,Juan L. Young,Huda Y. Zoghbi,Huda Y. Zoghbi,Laura A. Mamounas +20 more
TL;DR: A comprehensive summary of the physiological and behavioral phenotypes of RTT mouse models to date and areas in which further phenotypic analyses are required to enhance the utility of these models for translational studies are summarized.
Journal ArticleDOI
The Emerging Science of Interoception: Sensing, Integrating, Interpreting, and Regulating Signals within the Self.
Wen G. Chen,Dana Schloesser,Angela M. Arensdorf,Janine M. Simmons,Changhai Cui,Rita J. Valentino,James W. Gnadt,Lisbeth Nielsen,Coryse St Hillaire-Clarke,Victoria M. Spruance,Todd S. Horowitz,Yolanda F. Vallejo,Helene M. Langevin +12 more
TL;DR: Interoception refers to the representation of the internal states of an organism, and includes the processes by which it senses, interprets, integrates, and regulates signals from within itself as discussed by the authors.
Journal ArticleDOI
The NINDS Parkinson's disease biomarkers program
Liana S. Rosenthal,Daniel Drake,Roy N. Alcalay,Debra Babcock,F. DuBois Bowman,Alice Chen-Plotkin,Ted M. Dawson,Richard B. Dewey,Dwight C. German,Xuemei Huang,Barry Landin,Matthew J. McAuliffe,Vladislav A. Petyuk,Clemens R. Scherzer,Coryse St Hillaire-Clarke,Beth Anne Sieber,Margaret Sutherland,Chi Tarn,Andrew B. West,David E. Vaillancourt,Jing Zhang,Katrina Gwinn +21 more
TL;DR: The National Institute of Neurological Disorders and Stroke has established the Parkinson's Disease Biomarkers Program to promote discovery of PD biomarkers for use in phase II and III clinical trials.
Journal ArticleDOI
Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference.
Mustafa Sahin,Elizabeth P. Henske,Brendan D. Manning,Kevin C. Ess,John J. Bissler,Eric Klann,David J. Kwiatkowski,Steven L. Roberds,Alcino J. Silva,Coryse St Hillaire-Clarke,Lisa R. Young,Mark Zervas,Laura A. Mamounas +12 more
TL;DR: The new research plan is organized around both short-term and long-term goals with the expectation that progress toward specific objectives can be achieved within a five to ten year time frame.
Journal ArticleDOI
Parkinson's disease biomarkers: Perspective from the NINDS Parkinson's Disease Biomarkers Program
Katrina Gwinn,Karen K. David,Christine Swanson-Fischer,Roger L. Albin,Coryse St Hillaire-Clarke,Beth Anne Sieber,Codrin Lungu,F. DuBois Bowman,Roy N. Alcalay,Debra Babcock,Ted M. Dawson,Richard B. Dewey,Tatiana Foroud,Dwight C. German,Xuemei Huang,Vlad Petyuk,Judith A. Potashkin,Rachel Saunders-Pullman,Margaret Sutherland,David R. Walt,Andrew B. West,Jing Zhang,Alice Chen-Plotkin,Clemens R. Scherzer,David E. Vaillancourt,Liana S. Rosenthal +25 more
TL;DR: The role of the PDBP in PD biomarker identification is discussed in this paper, where the authors present guidelines to facilitate their development, including harmonizing procedures for biofluid acquisition and clinical assessments, replication of the most promising biomarkers, support and encouragement of publications that report negative findings, longitudinal follow-up of current cohorts including the PDBP, testing of wearable technologies to capture readouts between study visits and development of recently diagnosed (de novo) cohorts to foster identification of the earliest markers of disease onset.